The U.S. Food and Drug Administration requires more time to decide on whether to approve use of Moderna's two-dose COVID-19 vaccine on adolescents 12 to 17 years of age, the pharmaceutical company ...

The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, ...

Food and Drug Administration scientists Friday released their assessment of Moderna's coronavirus vaccine for the youngest children, as well as for older children and adolescents. (Frederic J ...

The action by the Food and Drug Administration means the agency has completed the same rigorous, time-consuming review of Moderna's shot as dozens of other long-established vaccines.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced it has completed the rolling submission process for its Biologics License Application to ...

The Food and Drug Administration (FDA) on Friday cleared the nation’s second coronavirus vaccine, giving additional hope that the end of the pandemic could be in sight. The official emergency ...

Get critical insights with Premium » Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1 Sep. 02, 2024 7:00 AM ET Moderna, Inc. (MRNA) ...

December 17, 2020 | Part Of FDA Advisory Committee Votes 20-0 to Recommend Moderna COVID-19 Vaccine Food and Drug Administration Open Meeting on Moderna COVID-19 Vaccine, Part 1 ...